ArticleInternational journal of clinical oncology2020

The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.

Jia-Yong Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.